Recessive Dystrophic Epidermolysis Bullosa (RDEB): Clinical Trials

1 trial for Recessive Dystrophic Epidermolysis Bullosa (RDEB), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Recessive Dystrophic Epidermolysis Bullosa (RDEB): new trials by email Literature Review of Recessive Dystrophic Epidermolysis Bullosa (RDEB) trials Research Report on Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds
Non-conforming pz-cel surgical application to RDEB wounds, Additional biopsies, Pz-cel surgical application to DEB wounds - Epidermolysis Bullosa (EB), Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Phase 4Not yet recruitingAbeona Therapeutics, Inc1002026-11-012026-08-06

Narrower conditions

Epidermolysis Bullosa (1)  ·  Epidermolysis Bullosa Dystrophica (1)

Broader conditions

Collagen Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Skin Abnormalities (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin Diseases, Vesiculobullous (1)  ·  Skin and Connective Tissue Diseases (1)

Sponsors

Abeona Therapeutics, Inc (1)